Epidemiology of chikungunya in the americas

Journal of Infectious Diseases

Volumn 214, Issue , 2016, Pages S441-S445

  Yactayo, Sergio ^a   Staples, J Erin ^b   Millot, Véronique ^a   Cibrelus, Laurence ^a   Ramon Pardo, Pilar ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Americas; Arbovirus; Chikungunya; Emerging disease; Epidemiology

Indexed keywords

ANTIVIRAL THERAPY; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CHRONIC ARTHRITIS; CLIMATE CHANGE; CONFERENCE PAPER; DISEASE SEVERITY; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; GLOBAL DISEASE BURDEN; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MORBIDITY; NONHUMAN; RISK ASSESSMENT; VIRUS TRANSMISSION; WESTERN HEMISPHERE; AEDES; ANIMAL; CHIKUNGUNYA FEVER; COMMUNICABLE DISEASES, EMERGING; COMPLICATION; EMBRYOLOGY; GENETICS; IMMUNOLOGY; MOLECULAR EVOLUTION; MOSQUITO VECTOR; PHYSIOLOGY; VIROLOGY;

AEDES; AMERICAS; ANIMALS; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CLIMATE CHANGE; COMMUNICABLE DISEASES, EMERGING; EVOLUTION, MOLECULAR; HUMANS; MOSQUITO VECTORS; RISK ASSESSMENT;

EID: 85015925058     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw390     Document Type: Conference Paper

References (27)

1. Gerardin P, Guernier V, Perrau J, et al. Estimating chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 2008; 8:99.
2. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009; 49:942-8.
3. Nakkhara P, Chongsuvivatwong V, Thammapalo S. Risk factors for symptomatic and asymptomatic chikungunya infection. Trans R Soc Trop Med Hyg 2013; 107:789-96.
4. Ayu SM, Lai LR, Chan YF, et al. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. Am J Trop Med Hyg 2010; 83:1245-8.
5. Genderen FT, Krishnadath I, Sno R, Grunberg MG, Zijlmans W, Adhin MR. First chikungunya outbreak in Surinam; clinical and epidemiological features. PLoS Negl Trop Dis 2016; 10:e0004625.
6. Gérardin P, Sampériz S, Ramful D, et al. Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island. PLoS Negl Trop Dis 2014; 8:e2996.
7. Arpino C, Curatolo P, Rezza G. Chikungunya and the nervous system: what we do and what we do not know. Rev Med Virol 2009; 19:121-9.
8. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3:e201.
9. Halstead SB. Reappearance of chikungunya, formerly called dengue, in the Americas. Emerg Infect Dis 2015; 21:557-61.
10. Kuno G. A re-examination of the history of etiologic confusion between dengue and chikungunya. PLoS Negl Trop Dis 2015; 9:e0004101.
11. Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill 2014; 19:pii=20752.
12. Pan American Health Organization. Number of reported cases of CHIK fever in the Americas by country or territory 2013-2014, and 2015. http://www. paho. org/ hq/index. php?option=com-topics&view=readall&cid=5927&Itemid=40931&lang=en. Accessed 2 May 2016.
13. Pimentel R, Skewes-Ramm R, Moya J. Chikungunya in the Dominican Republic: lessons learned in the first six months (in Spanish). Rev Panam Salud Publica 2014; 36:336-41.
14. Chikungunya: case definitions for acute, atypical and chronic cases. Conclusions of an expert consultation, Managua, Nicaragua, 20-21 May 2015. Wkly Epidemiol Rec 2015; 90:410-4.
15. Sergon K, Yahaya AA, Brown J, et al. Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros. Am J Trop Med Hyg 2007; 76:1189-93.
16. Economopoulou A, Dominguez M, Helynck B, et al. Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect 2009; 137:534-41.
17. Cardona-Ospina JA, Henao-SanMartin V, Paniz-Mondolfi AE, Rodriguez-Morales AJ. Mortality and fatality due to Chikungunya virus infection in Colombia. J Clin Virol 2015; 70:14-5.
18. Feldstein LR, Ellis EM, Rowhani-Rahbar A, Halloran EM, Ellis BR. The First Reported Outbreak of Chikungunya in the U. S. Virgin Islands, 2014-2015. Am J Trop Med Hyg. 2016; pii: 16-0288.
19. Moya J, Pimentel R, Puello J. Chikungunya: un reto para los servicios de salud de la República Dominicana. Rev Panam Salud Publica 2014; 36:331-5.
20. Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. Journal of General Virology 2007; 88:2363-77.
21. Simon F, Javelle E, Cabie A, et al. Société de pathologie infectieuse de langue francaise. French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Med Mal Infect 2015; 45:243-63.
22. Rodriguez-Morales AJ, Cardona-Ospina JA, Villamil-GomezW, Paniz-Mondolfi AE. How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America? Rheumatol Int 2015; 35:2091-4.
23. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med 2008; 5:e60.
24. Méndez JC, Abadi A. How much does the Chikungunya epidemic cost in Venezuela [in Spanish]? http://prodavinci. com/blogs/quiere-saber-cuanto-costola-epidermia-de-chikungunya-en-venezuela-por-julio-castro-y-anabella-abadi/. Accessed 2 May 2016.
25. Inoue S, Morita K, Matias RR, et al. Distribution of three arbovirus antibodies among monkeys (Macaca fascicularis) in the Philippines. J Med Primatol 2003; 32:89-94.
26. Almeida MA, Cardoso Jda C, Dos Santos E, et al. Surveillance for yellow Fever virus in non-human primates in southern Brazil, 2001-2011: a tool for prioritizing human populations for vaccination. PLoS Negl Trop Dis 2014; 8:e2741.
27. World Health Organization (WHO). Risk assessment on yellow fever virus circulation in endemic countries. Working document from an informal consultation of experts. A protocol for risk assessment at the field level. Geneva, Switzerland: WHO, 2014.